Encouraged
by the success of Win-Medicare, another landmark joint-venture was
formed to serve the health needs of the country. Christened
Modi-Mundipharma Ltd., the tie-up with the Mundipharma
Group of Switzerland has
further strengthened the Group’s position in the pharmaceutical
segment.
Napp
Pharmaceuticals, UK (Mundipharma Group)
A
rapidly growing pharma company, Modi-Mundipharma draws its
primary strength from
sound Research and Development as well as existing and effective
formulations of the Mundipharma Group companies world-wide. Medical
fraternity, across the length and breadth of India, perceives
Modi-Mundipharma to be a pharma company that offers long acting
formulations in specialised therapeutic segments.
Modi-Mundipharma has reached this position with consistent exposure
of the benefits of revolutionary Continus technology at large and
subsequent discussions of the brand benefits derived from controlled
drug delivery.
The focus
of Modi-Mundipharma is to offer state-of-the-art and latest
high-tech pharmaceutical solutions through introduction of
differentiated products in the field of Asthma, Pain and Heart
diseases. The company is effectively represented in the Domestic
and South Asian markets.
